144 related articles for article (PubMed ID: 22231581)
1. CT and MRI in monitoring response: state-of-the-art and future developments.
D'Ippolito G; Torres LR; Saito Filho CF; Ferreira RM
Q J Nucl Med Mol Imaging; 2011 Dec; 55(6):603-19. PubMed ID: 22231581
[TBL] [Abstract][Full Text] [Related]
2. Imaging of therapy response in oncology.
Chiti A; Oyen WJ
Q J Nucl Med Mol Imaging; 2011 Dec; 55(6):587-8. PubMed ID: 22231579
[No Abstract] [Full Text] [Related]
3. (18)F-FDG-PET/CT in evaluating response to therapy in solid tumors: where we are and where we can go.
Herrmann K; Benz MR; Krause BJ; Pomykala KL; Buck AK; Czernin J
Q J Nucl Med Mol Imaging; 2011 Dec; 55(6):620-32. PubMed ID: 22231582
[TBL] [Abstract][Full Text] [Related]
4. Response assessment in oncology: limitations of anatomic response criteria in the era of tailored treatments.
Carnaghi C; Sclafani F; Basilico V; Doherty M
Q J Nucl Med Mol Imaging; 2011 Dec; 55(6):589-602. PubMed ID: 22231580
[TBL] [Abstract][Full Text] [Related]
5. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
6. Tumor response assessments with diffusion and perfusion MRI.
Li SP; Padhani AR
J Magn Reson Imaging; 2012 Apr; 35(4):745-63. PubMed ID: 22434697
[TBL] [Abstract][Full Text] [Related]
7. Use of PET/CT to evaluate response to therapy in lymphoma.
Zanoni L; Cerci JJ; Fanti S
Q J Nucl Med Mol Imaging; 2011 Dec; 55(6):633-47. PubMed ID: 22231583
[TBL] [Abstract][Full Text] [Related]
8. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease.
Horger M; Bares R
Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146
[TBL] [Abstract][Full Text] [Related]
9. Current concepts in the evaluation of multiple myeloma with MR imaging and FDG PET/CT.
Hanrahan CJ; Christensen CR; Crim JR
Radiographics; 2010 Jan; 30(1):127-42. PubMed ID: 20083590
[TBL] [Abstract][Full Text] [Related]
10. Imaging techniques to evaluate the response to treatment in oncology: current standards and perspectives.
Marcus CD; Ladam-Marcus V; Cucu C; Bouché O; Lucas L; Hoeffel C
Crit Rev Oncol Hematol; 2009 Dec; 72(3):217-38. PubMed ID: 18760935
[TBL] [Abstract][Full Text] [Related]
11. [CT and MR imaging in the evaluation and staging of lung cancer].
Kuriyama K; Kadota T; Kuroda C
Gan To Kagaku Ryoho; 1990 Nov; 17(11):2140-7. PubMed ID: 2173493
[TBL] [Abstract][Full Text] [Related]
12. Therapy response assessment in radiotherapy of lung cancer.
Van Elmpt W; Pöttgen C; De Ruysscher D
Q J Nucl Med Mol Imaging; 2011 Dec; 55(6):648-54. PubMed ID: 22231584
[TBL] [Abstract][Full Text] [Related]
13. Therapy Monitoring with Functional and Molecular MR Imaging.
García-Figueiras R; Padhani AR; Baleato-González S
Magn Reson Imaging Clin N Am; 2016 Feb; 24(1):261-288. PubMed ID: 26613885
[TBL] [Abstract][Full Text] [Related]
14. Brain perfusion: computed tomography applications.
Miles KA
Neuroradiology; 2004 Dec; 46 Suppl 2():s194-200. PubMed ID: 15645152
[TBL] [Abstract][Full Text] [Related]
15. Molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging.
Schiepers C; Dahlbom M
Eur Radiol; 2011 Mar; 21(3):548-54. PubMed ID: 21174096
[TBL] [Abstract][Full Text] [Related]
16. Assessing tumor response to therapy.
Weber WA
J Nucl Med; 2009 May; 50 Suppl 1():1S-10S. PubMed ID: 19380403
[TBL] [Abstract][Full Text] [Related]
17. Letter to the editor re: molecular imaging in oncology: the acceptance of PET/CT and the emergence of MR/PET imaging.
Sauter A; Kolb A; Soekler M; Reimold M; Schwenzer N; Pfannenberg C; Claussen C; Pichler B; Horger M
Eur Radiol; 2011 Aug; 21(8):1709-12. PubMed ID: 21380639
[No Abstract] [Full Text] [Related]
18. PET/CT: panacea, redundancy, or something in between?
Vogel WV; Oyen WJ; Barentsz JO; Kaanders JH; Corstens FH
J Nucl Med; 2004 Jan; 45 Suppl 1():15S-24S. PubMed ID: 14736832
[TBL] [Abstract][Full Text] [Related]
19. [Targeted treatments: which imaging?].
Lassau N; Chebil M; Benatsou B; Chami L; Roche A
Bull Cancer; 2008 Oct; 95(10):989-93. PubMed ID: 19004731
[TBL] [Abstract][Full Text] [Related]
20. [Imaging in cerebrovascular atherosclerotic disease].
Siebler M; Junghans U; Fiebach JB
Herz; 2008 Nov; 33(7):482-8. PubMed ID: 19066744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
